ANAB - ANAPTYSBIO INC
Form S-1 Period: OCT.10.17 Date Filed: OCT.10.17
Transcript Split
  
  
     
Move to First Section Move to Last Section
INDEX
ItemizedPage-by-Page
  Form S-1 (Entire Filing)

Filing Body

Page 1: As filed with the Securities and Exchange Commission on October 10, 2017

Page 2: Investing in our common stock involves a high degree of risk. See Risk Factors on page 15 of this pr

Page 3: TABLE OF CONTENTS

Page 4: PROSPECTUS SUMMARY

Page 5: N/A

Page 6: N/A

Page 7: Our Product Candidates

Page 8: N/A

Page 9: The Advantages of Our SHM Platform

Page 10: Our Collaborations

Page 11: Our Strategy

Page 12: Risks Affecting Us

Page 13: Implications of Being an Emerging Growth Company

Page 14: THE OFFERING

Page 15: N/A

Page 16: Summary Consolidated Financial Data

Page 17: N/A

Page 18: RISK FACTORS

Page 19: SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Page 20: N/A

Page 21: MARKET AND INDUSTRY DATA

Page 22: USE OF PROCEEDS

Page 23: MARKET PRICE OF OUR COMMON STOCK

Page 24: CAPITALIZATION

Page 25: N/A

Page 26: DILUTION

Page 27: N/A

Page 28: CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

Page 29: Participation in our Initial Public Offering

Page 30: Amended and Restated Investors Rights Agreement

Page 31: PRINCIPAL STOCKHOLDERS

Page 32: N/A

Page 33: N/A

Page 34: DESCRIPTION OF CAPITAL STOCK

Page 35: Warrants

Page 36: Piggyback Registration Rights

Page 37: Restated Certificate of Incorporation and Restated Bylaw Provisions

Page 38: Transfer Agent and Registrar

Page 39: MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS

Page 40: Non-U.S. Holder Defined

Page 41: Sale of Common Stock

Page 42: U.S. Federal Estate Tax

Page 43: Foreign Account Tax Compliance Act

Page 44: UNDERWRITING

Page 45: N/A

Page 46: N/A

Page 47: Selling Restrictions:

Page 48: Notice to Prospective Investors in the United Kingdom

Page 49: Statutory Rights of Action

Page 50: Notice to Prospective Investors in the Republic of Italy

Page 51: Wertpapierprospektgesetz

Page 52: Notice to Prospective Investors in Israel

Page 53: Notice to Prospective Investors in Singapore

Page 54: Notice to Prospective Investors in China

Page 55: Notice to Prospective Investors in the Cayman Islands

Page 56: LEGAL MATTERS

Page 57: N/A

Page 58: AnaptysBio, Inc.

Page 59: PART II

Page 60: ITEM 15. RECENT SALES OF UNREGISTERED SECURITIES.

Page 61: (b) Warrants

Page 62: N/A

Page 63: ITEM 17. UNDERTAKINGS.

Page 64: bona fide

Page 65: SIGNATURES

Page 66: Signature

Exhibits

   CURRENT PAGE
    Download Current Page as a Word Document  Download Current Page as a PDF Document    Download Excel File of Financials